Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
13/05/2025
Barclays: Maintains a rating of hold for Iovance Biotherapeutics (IOVA.US), adjusting it from hold to buy, with a target price adjusted from $5.00 to $4.00.
Latest
3 m ago
Google Inc. launched an AI Future Fund to invest in collaborations with startups.
3 m ago
Google has launched the AI Future Fund, which will invest in collaborations with startups.
4 m ago
The National Copper Company of Chile and BHP reached a consensus in the exploration of the Anillo property.
4 m ago
The Chilean National Copper Corporation (Codelco) and BHP have reached an agreement regarding the exploration of the Anillo property.
6 m ago
The US stock market continued to rise, with the S&P 500 index up by 3.00%.
See all latest